Drug
TS-142 clinical trials
Also written TS-142.
- studies test it
- 15
- open now
- 0
- in phase 3
- 2
- first study started
- 2016
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
15 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 3
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 0
Taisho Pharmaceutical Co., Ltd. (14) · Taisho Pharmaceutical R&D Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses TS-142 is read from its arms, and is right about nine times in ten.
Testing it · 15
- Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia DisorderCompletedPhase 2Taisho Pharmaceutical Co., Ltd.NCT04573725Written as TS-142
- A Pharmacokinetic Study of TS-142 in Patients with Hepatic ImpairmentCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05624944Written as TS-142 5 mg
- A QT/QTc Evaluation Study of TS-142 in Healthy Adult SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04873323Written as TS-142
- Late Phase II Study of TS-142 in Patients with InsomniaCompletedPhase 2Taisho Pharmaceutical Co., Ltd.NCT04469023Written as TS-142
- A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05819710Written as TS-142
- Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04557163Written as TS-142
- Phase III Study of TS-142 in Patients with InsomniaCompletedPhase 3Taisho Pharmaceutical Co., Ltd.NCT05453136Written as TS-142 5 mg
- A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04169906Written as TS-142, 10 mg
- A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04696952Written as TS-142
- Long-Term Study of TS-142 in Patients with InsomniaCompletedPhase 3Taisho Pharmaceutical Co., Ltd.NCT05461352Written as TS-142 5 mg
- A Food Effect Study of TS-142 in Healthy SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05707897Written as TS-142 10 mg
- A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04746105Written as TS-142
- Mass Balance Study of TS-142 in Healthy Adult Subjects.CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04814771Written as [14C] TS-142
- Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy SubjectsCompletedPhase 2Taisho Pharmaceutical Co., Ltd.NCT04087707Written as Step 1: TS-142
- A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy ParticipantsCompletedPhase 1Taisho Pharmaceutical R&D Inc.NCT04464239Written as TS-142